Implant records IOP for a decade
A German study has found that an implanted telemetric intraocular pressure (IOP) sensor continued to function and was well tolerated in situ for almost 10 years.
Staff reporters1 min read
Ophthalmology News
IbisVision’s US funding drive
Glasgow-based optometry tech firm IbisVision is looking to raise £5m (NZ$9.4m) in the US to fund the roll out of its technology internationally.
Staff reporters2 min read
Sponsored
SPONSORED: Cataract surgery in retinal patients – achieving the best outcome
Many patients with retinal pathology will benefit from cataract surgery to improve media clarity and contrast. In these patients, accurate biometry is essential to guide precise intraocular lens (IOL) choice and allow our patients to achieve the best visual outcome. Retina Specialists now has the la
Staff reporters2 min read
Telehealth reduces inequities
Researchers at The University of Auckland have shown that telehealth could reduce health inequities for Māori whānau.
Staff reporters2 min read
Ordering Eschenbach magnifiers the easy way
MSO has launched a new site, NZ Magnifiers, featuring the full range of Eschenbach magnifiers and Daylight magnifying lamps, which it said provides a more efficient and thus speedier delivery system for single orders.
Staff reporters2 min read
Vabysmo nets FDA approval
Genentech’s Vabysmo (faricimab), the first bispecific antibody to treat neovascular age-related macular degeneration (wet AMD) and diabetic macular oedema (DMO), has received US Food and Drug Administration (FDA) approval.
Staff reporters1 min read
University tackles MRSA vaccine following Covid vaccine success
A University of Auckland (UoA) team is developing a Staphylococcus aureus vaccine based on mRNA technology developed to fight Covid-19.
Staff reporters3 min read
Alcoholism drug preserves vision
US researchers have found that disulfiram (Antabuse), a drug used to treat alcoholism, could help restore some vision in retinitis pigmentosa (RP) and age-related macular degeneration (AMD) patients.
Staff reporters2 min read
Post-Covid eye problems examined
A Swedish study is looking into why some people who have recovered from Covid-19 experience long-term eye problems and if the phenomenon can be measured using biological markers.
Staff reporters2 min read
Pop an aspirin to slow DR
A Taiwanese study has demonstrated some antiplatelet/anticoagulant (APAC) therapies, including aspirin, have a protective effect against diabetic retinopathy (DR) progression in diabetic
Staff reporters1 min read
Netarsudil’s extra IOP benefit
A US study has shown that netarsudil (Rhopressa) can offer additional intraocular pressure (IOP)-lowering effects in patients on maximally tolerated medical therapies for glaucoma. After reviewing
Staff reporters1 min read
New TED therapeutic?
ValenzaBio’s monoclonal antibody drug to treat thyroid eye disease (TED) has been cleared by the US Food and Drug Administration to enter phase 1a clinical trials. The drug, VB421, targets the
Staff reporters1 min read